Getinge Overview
- Year Founded
-
1904

- Status
-
Public
- Employees
-
11,791

- Stock Symbol
-
GETI B

- Investments
-
44
- Share Price
-
$19.46
- (As of Friday Closing)
Getinge General Information
Description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Contact Information
Website
www.getinge.comCorporate Office
- Lindholmspiren 7A
- PO Box 8861
- 417 56 Göteborg
- Sweden
Corporate Office
- Lindholmspiren 7A
- PO Box 8861
- 417 56 Göteborg
- Sweden
Getinge Stock Performance
As of 07-Feb-2025, Getinge’s stock price is $19.46. Its current market cap is $5.3B with 272M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$19.46 | $19.54 | $14.90 - $23.03 | $5.3B | 272M | 992K | $0.57 |
Getinge Financials Summary
As of 31-Dec-2024, Getinge has a trailing 12-month revenue of $3.29B.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 5,336,796 | 5,336,796 | 6,274,318 | 5,729,113 |
Revenue | 3,286,611 | 3,286,611 | 2,994,327 | 2,788,703 |
EBITDA | 464,923 | 464,923 | 531,371 | 533,866 |
Net Income | 154,880 | 154,880 | 226,924 | 245,543 |
Total Assets | 5,793,085 | 5,793,085 | 5,361,849 | 4,987,826 |
Total Debt | 972,221 | 972,221 | 808,090 | 558,293 |
Getinge Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Getinge Comparisons
Industry
Financing
Details
Getinge Competitors (15)
One of Getinge’s 15 competitors is Siemens Healthineers, a Corporation company based in Forchheim, Germany.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Siemens Healthineers | Corporation | Forchheim, Germany | ||||
SeaSpine Holdings | Corporate Backed or Acquired | Carlsbad, CA | ||||
Vyaire Medical | Private Equity-Backed | Mettawa, IL | ||||
Midmark | Corporation | Dayton, OH | ||||
NuVasive | Formerly VC-backed | San Diego, CA |
Getinge Patents
Getinge Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4434430-A1 | A channel irrigation system for flushing process medium through internal channels of a medical article | Pending | 24-Mar-2023 | ||
EP-4417223-A1 | A medical washer-disinfector | Pending | 15-Feb-2023 | ||
EP-4410177-A1 | A system for supplying a process medium to medical articles having multiple channels | Pending | 31-Jan-2023 | ||
EP-4501208-A2 | A system for supplying a process medium to medical articles having multiple channels | Pending | 31-Jan-2023 | ||
EP-4389158-A1 | A steam sterilizer system | Pending | 19-Dec-2022 | A61L2/07 |
Getinge Signals
Getinge Acquisitions (44)
Getinge’s most recent deal was a Merger/Acquisition with Paragonix for . The deal was made on 11-Sep-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Paragonix | 11-Sep-2024 | Merger/Acquisition | Other Devices and Supplies | ||
Healthmark Industries | 11-Oct-2023 | Merger/Acquisition | Surgical Devices | ||
High Purity New England | 04-Oct-2023 | Merger/Acquisition | Other Devices and Supplies | ||
Ultra Clean Systems | 14-Mar-2023 | Merger/Acquisition | Other Devices and Supplies | ||
Fluoptics | 01-Jul-2022 | Merger/Acquisition | Surgical Devices |
Getinge ESG
Risk Overview
Risk Rating
Updated December, 03, 2024
22.8 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,120
Rank
Percentile

Healthcare
Industry
of 587
Rank
Percentile

Medical Devices
Subindustry
of 199
Rank
Percentile

Getinge Exits (4)
Getinge’s most recent exit was on 04-Jul-2012 from Acare Medical Science. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Acare Medical Science | 04-Jul-2012 | Completed |
|
||
Odelga Med Engineering | 01-Jan-2010 | Completed |
|
||
Arjo | 01-Jan-1995 | Completed |
|
||
Lifco | 01-Jan-1995 | Merger/Acquisition | Completed |
Affiliates
Subsidiaries (13)
Name | Industry | Location | Year Founded |
---|---|---|---|
Getinge Ic Production Poland | Plewiska, Poland | 2014 | |
Talis Clinical | Streetsboro, OH | 2012 | |
IDS Medical Systems | Hong Kong, Hong Kong | 2011 | |
Paragonix | North Waltham, MA | 2010 | |
Getinge Cetrea | Aarhus, Denmark | 2006 |
Getinge FAQs
-
When was Getinge founded?
Getinge was founded in 1904.
-
Where is Getinge headquartered?
Getinge is headquartered in Göteborg, Sweden.
-
What is the size of Getinge?
Getinge has 11,791 total employees.
-
What industry is Getinge in?
Getinge’s primary industry is Monitoring Equipment.
-
Is Getinge a private or public company?
Getinge is a Public company.
-
What is Getinge’s stock symbol?
The ticker symbol for Getinge is GETI B.
-
What is the current stock price of Getinge?
As of 07-Feb-2025 the stock price of Getinge is $19.46.
-
What is the current market cap of Getinge?
The current market capitalization of Getinge is $5.3B.
-
What is Getinge’s current revenue?
The trailing twelve month revenue for Getinge is $3.29B.
-
Who are Getinge’s competitors?
Siemens Healthineers, SeaSpine Holdings, Vyaire Medical, Midmark, and NuVasive are some of the 15 competitors of Getinge.
-
What is Getinge’s annual earnings per share (EPS)?
Getinge’s EPS for 12 months was $0.57.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »